From OCR to AI The Future of Media and Image Analysis in eDiscovery
Episode 373 -- Christian Focacci on Current Developments in AI and Risk Management
CareYaya: A Revolutionary Approach to Elder Care
No Password Required: CEO of HACKERverse.ai, Disruptor of Cybersecurity Sales and Most Other Things
Brooklyn District Attorney Eric Gonzalez – Innovative Approach to Safety
JONES DAY TALKS®: Women in IP – AI and Copyright Law Need-to-Knows
Hilary Preston, Vice Chair at Vinson & Elkins, Discusses Energy Innovation: Protecting Your Intellectual Property Portfolio
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 228: Designing & Manufacturing Auto-Injectors with Kimberlee Steele of SHL Medical
Innovation in Compliance: Visionary Leadership with Jackson Calame
A Thermal Storage Revolution With Nis Benn, Hyme Energy — Battery + Storage Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 225: Cancer Care Access & Treatments with Dr. Sengar of Alabama Cancer Care
Building a Business at the Intersection of Neurodata and Innovation With Rob Cooley
Approach to Responsible AI
Creating Impact Through Innovation: Brandon Kashani on Leading Mission-Driven Startups
Bridging the Gap: How CivicReach is Revolutionizing Government Customer Service
Podcast — Drug Pricing: 2025 J.P. Morgan Healthcare Conference Takeaways and Outlook
Podcast — UK FinReg Focus Areas in 2025: Sectoral Trends
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 218: Artificial Intelligence in Drug Development with John Van Hoy of PPD & Thermo Fisher
Driving Towards Greater Transparency and Sustainability in the EV Market with Davide Giacobbe and ScoutIt
Crafting an Effective Law Firm Generative AI Policy for Responsible Business Use: On Record PR
On April 15, 2025, Canada’s Drug Agency (CDA) released its new five-year strategic plan, Insight to Impact 2025-2030. Formerly the Canadian Agency for Drugs and Technologies in Health (CADTH), this is the CDA’s first...more
In this hoganlovells.com Q&A, Hogan Lovells counsel Fabien Roy addresses EU regulations that apply to medical devices that are produced using 3-D printing technologies....more